Covered recipient · General Payments record
VIRAAJ PRATAP SINGH PANNU
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2024
$264.83
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $264.83 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $88.87 | 5 |
| ABBVIE INC. | $50.26 | 3 |
| PROCYRION, INC. | $23.15 | 1 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $20.29 | 1 |
| Kestra Medical Technology Services, Inc. | $17.81 | 1 |
| Ancora Heart, Inc. | $17.42 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.06 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.76 | 1 |
| Lexicon Pharmaceuticals, Inc. | $14.21 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $264.83 | 15 |
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.80 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105176298 | CMS |
| ABBVIE INC. | $17.01 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105176300 | CMS |
| ABBVIE INC. | $16.45 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105176302 | CMS |
| Ancora Heart, Inc. | $17.42 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067446372 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.76 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101252058 | CMS |
| Kestra Medical Technology Services, Inc. | $17.81 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152373577 | CMS |
| Lexicon Pharmaceuticals, Inc. | $14.21 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081723959 | CMS |
| Novartis Pharmaceuticals Corporation | $17.06 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087339649 | CMS |
| PFIZER INC. | $17.06 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131605652 | CMS |
| PFIZER INC. | $15.16 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131604807 | CMS |
| PFIZER INC. | $19.00 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131609835 | CMS |
| PFIZER INC. | $19.00 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131610632 | CMS |
| PFIZER INC. | $18.65 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131610636 | CMS |
| PROCYRION, INC. | $23.15 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143646407 | CMS |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $20.29 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074301573 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.